O'Shaughnessy Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $30,595 - $37,230	399 Added 9.64%	4,538 $413,000
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $232 - $334	5 Added 0.12%	4,139 $273,000
Q4 2022 Feb 10, 2023	BUY	$43.24 - $61.04 $389 - $549	9 Added 0.22%	4,134 $213,000
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $184,635 - $287,347	4,125 New	4,125 $282,000
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $92,404 - $147,774	-3,006 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$31.4 - $69.84 $16,861 - $37,504	537 Added 21.75%	3,006 $99,000
Q2 2021 Aug 09, 2021	BUY	$40.9 - $64.9 $100,982 - $160,238	2,469 New	2,469 $156,000

302

112M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.19B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.